EL HAJBI , F.

Last name: EL HAJBI

First name: F.

October 7, 2016 (v1)

Conference paper

Metadata-only

Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20

Aparicio, T. Bouché, O. Francois, E.

International audience

Uploaded on: February 28, 2023
April 2019 (v1)

Journal article

Metadata-only

Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS)

Adenis, Antoine Bennouna, J. Etienne, P.L.

PURPOSE:The role of chemotherapy has not been established in the treatment of metastatic squamous cell oesophageal cancer (mESCC).PATIENTS AND METHODS:E-DIS is a discontinuation trial, aimed at estimating efficacy, quality of life and safety of chemotherapy continuation (CT-CONT) in patients with mESCC who are free from progression after a...

Uploaded on: December 4, 2022
July 2018 (v1)

Journal article

Metadata-only

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

Aparicio, T. Bouché, O. Francois, E.

BackgroundOlder patients have frailty characteristics that impair the transposition of treatment results found in younger patients. Predictive factors are needed to help with treatment choices for older patients. The PRODIGE 20 study is a randomized phase II study that evaluated chemotherapy associated with bevacizumab (BEV) or not (CT) in...

Uploaded on: December 4, 2022

EL HAJBI , F.

Recent uploads